XML 61 R53.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting - Schedule of Segment Revenue, Segment Profit and Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total revenues $ 244,317 $ 205,831
Cost of goods sold 20,392 22,951
Research and development 78,265 59,679
Selling, general and administrative 126,370 107,991
Interest income, net 7,901 5,506
Other income 588 286
Income tax expense 8,792 4,447
Net Income (Loss) 18,987 16,555
Reportable Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenues 244,317 205,831
Cost of goods sold 9,211 10,074
License fees and royalties 11,181 12,877
Research and development 78,265 59,679
Selling, general and administrative 126,370 107,991
Interest income, net (7,901) (5,506)
Other income (588) (286)
Income tax expense 8,792 4,447
Net Income (Loss) 18,987 16,555
Reportable Segment [Member] | External research and development    
Segment Reporting Information [Line Items]    
Research and development 54,985 41,489
Reportable Segment [Member] | Internal costs    
Segment Reporting Information [Line Items]    
Research and development [1] 23,280 18,190
NUPLAZID | Reportable Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenues 159,721 129,923
DAYBUE | Reportable Segment [Member]    
Segment Reporting Information [Line Items]    
Total revenues $ 84,596 $ 75,908
[1] Includes personnel expenses and costs allocated to multiple research and development programs, including benefits, information technology, facilities and inventory.